Annexon (ANNX) Minority Interest (2019 - 2020)
Annexon (ANNX) posted quarterly Minority Interest of $235.1 million for Q2 2020, up 129.06% year-over-year from $102.6 million in Q3 2019, and up 62.93% quarter-over-quarter from $144.3 million in Q1 2020.
Annexon (ANNX) Minority Interest (2019 - 2020) Analysis & Trends
Annexon's Minority Interest history runs 2 years deep, the most recent figure standing at $235.1 million for Q2 2020.
- In Q2 2020, Minority Interest rose 129.06% year-over-year to $235.1 million; the TTM figure through Jun 2020 stood at $235.1 million (up 129.06% YoY), while the FY2019 annual figure was $144.0 million, changed N/A from the prior year.
- Minority Interest for Q2 2020 stood at $235.1 million, up from $144.3 million in the prior quarter.
- The five-year high for Minority Interest was $235.1 million in Q2 2020, with the low at $10.8 million in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Annexon | 1.00 Bn | 1.00 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 235.05 Mn |
| Mar 31, 2020 | 144.26 Mn |
| Dec 31, 2019 | 143.98 Mn |
| Sep 30, 2019 | 10.81 Mn |
| Jun 30, 2019 | 102.62 Mn |